This is a significant update insofar as I previously thought ASPEN-OLS enrollment would be delayed on account of COVID-19 (#msg-154310354).
Reminder: ASPEN-OLS and ASPEN-1 (where all patients have competed treatment and are being followed for observation) comprise the full phase-3 package for Daxi in cervical dystonia (#msg-148887973).
*Open-Label Safety.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.